Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
This guide walks through factors to consider when choosing between BTC and ETH for a first purchase, including risk tolerance and goals.
27,350 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
A fresh court filing broadens a veteran-focused mortgage case, accusing Veterans United of bait-and-switch tactics an...
The allianz 2025 annual retirement study reveals a 13-point drop in confidence since 2020. Inflation and rising housi...
As tax policy and market conditions shift, a growing number of retirees with $2 million in retirement accounts seek g...
In a market thirsting for the next big tech winner, the steady power of dividend growth often goes unseen. This artic...
A major fiscal analysis warns that Social Security could suffer a 24% across-the-board cut by 2032, costing about $50...
Two energy infrastructure ETFs are under the lens as crude markets stay volatile. EMLP and ENFR continue payouts, but...
The Pentagon reports a dramatic rise in AI usage, but fewer than half of employees are actively using tools. Experts ...
San Francisco-based Framework Ventures closes its fourth fund at $400 million, expanding beyond crypto into frontier ...
Rivian ranks at the bottom of the JD Power 2026 Initial Quality Study, recording 246 problems per 100 vehicles in the...
Could Green Thumb Industries be trading below its true value? This guide weighs the fundamentals, catalysts, and risk...
Pakistan's crypto regulators held talks with Islamic scholars after a fatwa labeled crypto purchases impermissible, s...